| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ASTH
Astrana Health
|
Aug 07, 2026 | BUY |
Strong Buy
+63.4% avg upside
16 analysts
|
— | · | · |
|
DOCS
Doximity
|
Aug 07, 2026 | HOLD |
Buy
+25.2% avg upside
28 analysts
|
— | +0.0% | · |
|
PRVA
Privia Health Group
|
Aug 07, 2026 | BUY |
Strong Buy
+42.1% avg upside
26 analysts
|
— | · | · |
|
PGNY
Progyny
|
Aug 07, 2026 | BUY |
Strong Buy
+16.1% avg upside
14 analysts
|
— | +0.0% | · |
|
AGL
Agilon Health
|
Aug 06, 2026 | HOLD |
Buy
-30.8% avg upside
26 analysts
|
$112.00
17.24% Upside
|
· | · |
|
MDLN
Medline
|
Aug 06, 2026 | BUY |
Strong Buy
+37.1% avg upside
27 analysts
|
$47.00
33.40% Upside
|
+2.1% | · |
|
BTMD
biote
|
Aug 06, 2026 | BUY |
Strong Buy
+208.8% avg upside
8 analysts
|
— | · | · |
|
GDRX
GoodRx Holdings
|
Aug 06, 2026 | HOLD |
Buy
+245.3% avg upside
28 analysts
|
— | -1.1% | · |
|
AMWL
American Well
|
Aug 05, 2026 | HOLD |
Buy
+5.6% avg upside
15 analysts
|
— | +0.0% | · |
|
HNGE
Hinge Health, Inc. Class A
|
Aug 05, 2026 | BUY |
Strong Buy
+5.2% avg upside
17 analysts
|
— | +10.6% | · |
|
ICLR
Icon
|
Jul 31, 2026 | BUY |
Strong Buy
+14.8% avg upside
26 analysts
|
$209.00
27.08% Upside
|
+0.6% | · |
|
TDOC
Teladoc
|
Jul 30, 2026 | HOLD |
Buy
+306.6% avg upside
38 analysts
|
— | +1.5% | · |
|
WAY
Waystar Holding Corp.
|
Jul 30, 2026 | BUY |
Strong Buy
+53.2% avg upside
30 analysts
|
— | +15.7% | · |
|
FTRE
Fortrea Holdings Inc.
|
Jul 30, 2026 | BUY |
Buy
+14.2% avg upside
12 analysts
|
$26.00
41.02% Upside
|
-3.4% | · |
|
IQV
IQVIA Holdings
|
Jul 29, 2026 | BUY |
Strong Buy
+1.6% avg upside
39 analysts
|
$300.00
25.75% Upside
|
-3.6% | · |
|
HIMS
Hims & Hers Health
|
Jul 28, 2026 | HOLD |
Buy
-15.0% avg upside
22 analysts
|
$27.00
14.58% Downside
|
+7.8% | · |
|
MEDP
Medpace Holdings
|
Jul 28, 2026 | HOLD |
Buy
-18.0% avg upside
17 analysts
|
$609.00
3.03% Upside
|
+3.5% | · |
|
EVH
Evolent Health
|
Jun 30, 2026 | HOLD |
Strong Buy
+146.4% avg upside
19 analysts
|
$7.00
77.23% Upside
|
-33.0% | · |
|
PHR
Phreesia
|
Jun 12, 2026 | HOLD |
Strong Buy
+37.9% avg upside
21 analysts
|
— | +26.8% | · |
|
VEEV
Veeva Systems
|
Jun 04, 2026 | BUY |
Buy
+3.8% avg upside
37 analysts
|
$262.00
13.64% Upside
|
+29.0% | · |
|
ARDT
Ardent Health Partners, Inc.
|
Jun 03, 2026 | BUY |
Buy
+20.2% avg upside
16 analysts
|
— | +47.5% | · |
|
RVMD
Revolution Medicines
|
Feb 27, 2026 | BUY |
Strong Buy
-20.2% avg upside
32 analysts
|
$116.00
43.48% Downside
|
+101.1% | · |
|
CRMD
Cormedix
|
Sep 04, 2025 | BUY |
Strong Buy
+101.0% avg upside
13 analysts
|
— | -41.9% | · |
|
TSE:BHC
Bausch Health Companies
|
Jul 30, 2025 | HOLD |
Buy
+569.1% avg upside
29 analysts
|
— | -4.8% | · |
|
SMMT
Summit Therapeutics
|
Jul 17, 2025 | BUY |
Strong Buy
+104.8% avg upside
27 analysts
|
— | -50.0% | · |
|
CNC
Centene
|
Jul 02, 2025 | BUY |
Buy
+8.7% avg upside
29 analysts
|
— | +100.9% | · |
|
CI
Cigna
|
May 05, 2025 | BUY |
Strong Buy
+22.8% avg upside
29 analysts
|
— | -15.5% | · |
|
ELV
Elevance Health
|
Apr 21, 2025 | BUY |
Strong Buy
+14.4% avg upside
33 analysts
|
— | -17.6% | · |
|
SRRK
Scholar Rock Holding
|
Jan 13, 2025 | BUY |
Strong Buy
+8.3% avg upside
23 analysts
|
— | +2.7% | · |
|
CHRS
Coherus Biosciences
|
Nov 19, 2024 | BUY |
Buy
+874.2% avg upside
18 analysts
|
— | +41.5% | · |
|
HUM
Humana
|
Oct 03, 2024 | HOLD |
Strong Buy
+8.6% avg upside
34 analysts
|
— | +19.0% | · |
|
AVAH
Aveanna Healthcare Holdings
|
Sep 09, 2024 | HOLD |
Buy
-1.2% avg upside
18 analysts
|
— | +50.7% | · |
|
CRBU
Caribou Biosciences
|
Sep 04, 2024 | BUY |
Strong Buy
+577.7% avg upside
12 analysts
|
— | -2.6% | · |
|
LLY
Eli Lilly & Co
|
Jul 03, 2024 | BUY |
Strong Buy
-11.7% avg upside
48 analysts
|
— | -12.5% | · |
|
HCA
HCA Healthcare
|
Apr 29, 2024 | BUY |
Buy
-2.3% avg upside
36 analysts
|
— | +10.2% | · |
|
PNTG
Pennant Group
|
Apr 16, 2024 | HOLD |
Strong Buy
-6.1% avg upside
9 analysts
|
$22.00
43.52% Downside
|
+30.9% | · |
|
UNH
UnitedHealth
|
Nov 29, 2022 | BUY |
Strong Buy
+12.0% avg upside
36 analysts
|
$610.00
49.87% Upside
|
+2.8% | · |
|
EHTH
Ehealth
|
Mar 03, 2022 | HOLD |
Hold
+1054.2% avg upside
19 analysts
|
$16.00
1067.78% Upside
|
-21.8% | · |
|
ACH
Accendra Health
|
Feb 28, 2022 | HOLD |
Hold
+521.1% avg upside
17 analysts
|
$43.00
1435.81% Upside
|
-65.3% | · |
|
DH
Definitive Healthcare Corp
|
Feb 24, 2022 | HOLD |
Hold
+683.5% avg upside
19 analysts
|
$24.00
3263.76% Upside
|
· | · |
|
SLQT
SelectQuote
|
Feb 08, 2022 | HOLD |
Buy
+1027.7% avg upside
16 analysts
|
$4.00
482.69% Upside
|
-56.1% | · |
|
CAH
Cardinal Health
|
Jan 07, 2022 | HOLD |
Buy
-16.6% avg upside
29 analysts
|
$62.00
73.85% Downside
|
+49.6% | · |
|
CLOV
Clover Health Investments
|
Jan 07, 2022 | SELL |
Hold
-22.1% avg upside
9 analysts
|
$3.50
26.45% Downside
|
+68.0% | · |
|
MCK
McKesson
|
Jan 07, 2022 | BUY |
Strong Buy
-13.1% avg upside
28 analysts
|
$333.00
61.75% Downside
|
+55.5% | · |
|
COR
Cencora
|
Jan 07, 2022 | BUY |
Buy
-0.4% avg upside
44 analysts
|
$180.00
43.93% Downside
|
+26.0% | · |
|
OSCR
Oscar Health
|
Nov 11, 2021 | BUY |
Buy
-23.0% avg upside
16 analysts
|
$21.00
24.73% Downside
|
-76.3% | · |
|
PI
IMPINJ
|
Feb 26, 2020 | BUY |
Strong Buy
-19.3% avg upside
16 analysts
|
$30.00
83.68% Downside
|
+103.8% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.